Can zapping a few tumor spots extend cancer treatment success?
NCT ID NCT07545486
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether using local ablative therapy (like radiation or surgery) on a limited number of tumor spots can improve outcomes for patients with solid tumors that responded to initial chemotherapy. The researchers will enroll over 1,200 patients with various cancer types and compare their response duration to historical data. The goal is to see if this approach can delay disease progression and improve survival, while also tracking side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
local ablative therapy (LAT)
What this could lead to
If successful, this approach could extend the time patients with certain solid tumors remain progression-free after initial treatment, potentially improving survival.
What could go wrong
This is a proof-of-concept study, not yet recruiting, and results are compared to historical data, not a control group. Local ablative therapy carries risks of serious side effects, including fatal complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American University of Beirut (AUB)
Beirut, Lebanon
Contact
Contact
-
Bank of Cyprus Oncology
Nicosia, 2006, Cyprus
Contact
Contact
-
CHIREC Hospital
Brussels, 1160, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Brugmann
Brussels, 1020, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Saint-Etienne
Saint-Priest-en-Jarez, 42270, France
Contact
Contact
-
Centre de Lutte contre le Cancer François Baclesse
Caen, 14000, France
Contact
Contact
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Grand Hôpital de Charleroi, site Notre Dame
Charleroi, 6000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HELORA Hôpital de Mons - Site Kennedy
Mons, 7000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Universitaire de Strasbourg
Strasbourg, 67200, France
Contact
Contact
-
Institut Paoli-Calmettes
Marseille, 13009, France
Contact
Contact
-
Oslo University Hospital / The Norwegian Radium Hospital
Oslo, Norway
Contact Email: •••••@•••••
Contact